⌘K

Login Start Free

Home/Filings/4/0001683168-22-001631

4//SEC Filing

Downs Christopher 4

Accession 0001683168-22-001631

CIK 0001729427other

View on SEC.gov Company Profile

Filed

Mar 13, 8:00 PM ET

Accepted

Mar 14, 9:40 AM ET

Size

4.4 KB

Accession

0001683168-22-001631

Insider Transaction Report

Form 4

Period: 2022-03-11

CNS Pharmaceuticals, Inc.CNSP

Downs Christopher

Chief Financial Officer

Transactions

Award
Common Stock
2022-03-11$0.31/sh+33,000$10,230→ 184,500 total

Documents

1 file

4
ownership.xmlPrimary

Issuer

CNS Pharmaceuticals, Inc.

CIK 0001729427

Entity typeother

Related Parties

1

filerCIK 0001705978

Filing Metadata

Form type: 4
Filed: Mar 13, 8:00 PM ET
Accepted: Mar 14, 9:40 AM ET
Size: 4.4 KB

View on SEC.gov